1,2,3,-Trimethylpyrazolium (-jodid) | 51113-32-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,2,3,-Trimethylpyrazolium (-jodid)
• 英文别名: 1,2,3-Trimethylpyrazolium；1,2,3-Trimethylpyrazol-1-ium
• CAS: 51113-32-7
• 化学式: C₆H₁₁N₂
• 分子量: 111.167
• InChiKey: DTUDMIINCAAINX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  8.8
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• [EN] BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS D'ARYLMONOBACTAME BICYCLIQUES ET LEURS MÉTHODES D'UTILISATION POUR LE TRAITEMENT DES INFECTIONS BACTÉRIENNES
  申请人：MERCK SHARP & DOHME

  公开号：WO2017155765A1

  公开（公告）日：2017-09-14

  The present invention relates to bicyclic aryl monobactam compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein A1, L, M, W, X, Y, Z, RX and Rz are as defined herein. The present invention also relates to compositions which comprise a bicyclic aryl monobactam compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The invention further relates to methods for treating a bacterial infection comprising administering to the patient a therapeutically effective amount of a compound of the invention, either alone or in combination with a therapeutically effective amount of one or more beta-lactamase inhibitor compounds.

  本发明涉及公式（I）的双环芳基单β内酰胺化合物及其药学上可接受的盐，其中A1、L、M、W、X、Y、Z、RX和Rz如本文所定义。本发明还涉及包含本发明的双环芳基单β内酰胺化合物或其药学上可接受的盐以及药学上可接受的载体的组合物。该发明还涉及治疗细菌感染的方法，包括向患者施用本发明化合物的治疗有效量，单独或与一种或多种β-内酰胺酶抑制剂化合物的治疗有效量结合使用。
• [EN] BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS DE BIARYLMONOBACTAME ET PROCÉDÉS D'UTILISATION CORRESPONDANTS POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：MERCK SHARP & DOHME

  公开号：WO2017106064A1

  公开（公告）日：2017-06-22

  The present invention relates to biaryl monobactam compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein X, Y, Z, A1, Q, A2, M, W, RX and Rz are as defined herein. The present invention also relates to compositions which comprise a biaryl monobactam compound of the invention or a pharmaceutically acceptable salt therof, and a pharmaceutically acceptable carrier. The invention further relates to methods for treating a bacterial infection comprising administering to the patient a therapeutically effective amount of a compound of the invention, either alone or in combination with a therapeutically effective amount of a second beta-lactam antibiotic.

  本发明涉及公式I的联苯单环内酰胺化合物及其药学上可接受的盐，其中X、Y、Z、A1、Q、A2、M、W、RX和Rz如本文所定义。本发明还涉及包含本发明的联苯单环内酰胺化合物或其药学上可接受的盐以及药学上可接受的载体的组合物。该发明还涉及治疗细菌感染的方法，包括向患者施用本发明化合物的治疗有效量，单独或与第二种β-内酰胺类抗生素的治疗有效量结合。
• CATALYSTS AND METHODS FOR POLYMER SYNTHESIS
  申请人：NOVOMER, INC.

  公开号：US20130144032A1

  公开（公告）日：2013-06-06

  The present invention provides unimolecular metal complexes having increased activity in the copolymerization of carbon dioxide and epoxides. Also provided are methods of using such metal complexes in the synthesis of polymers. According to one aspect, the present invention provides metal complexes comprising an activating species with co-catalytic activity tethered to a multidentate ligand that is coordinated to the active metal center of the complex.

  本发明提供了在二氧化碳和环氧化物的共聚合中具有增强活性的单分子金属配合物。还提供了使用这种金属配合物在合成聚合物中的方法。根据一个方面，本发明提供了包括与具有共催化活性的活化物种相耦合的多齿配体的金属配合物，该多齿配体与复合物的活性金属中心配位。
• Composition for the immediate stopping of a free-radical polymerization
  申请人：BASF SE

  公开号：US10221255B2

  公开（公告）日：2019-03-05

  A composition for the immediate stopping of a free-radical polymerization comprises a) an inhibitor for the free-radical polymerization selected from among phenothiazines, b) an aprotic solvent and c) an ionic liquid. It serves to stabilize free-radically polymerizable monomers against free-radical polymerization. For the immediate stopping of free-radical polymerizations, the composition is added to a free-radically polymerizing system.

  一种可立即阻止自由基聚合的组合物包括 a) 一种吩噻嗪类自由基聚合抑制剂；b) 一种烷基溶剂；c) 一种离子液体。其作用是稳定可自由基聚合的单体，防止自由基聚合。为了立即停止自由基聚合，可将该组合物加入自由基聚合体系中。
• Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
  申请人：Merck Sharp & Dohme Corp.

  公开号：US10407421B2

  公开（公告）日：2019-09-10

  The present invention relates to bicyclic aryl monobactam compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein A1, L, M, W, X, Y, Z, RX and Rz are as defined herein. The present invention also relates to compositions which comprise a bicyclic aryl monobactam compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The invention further relates to methods for treating a bacterial infection comprising administering to the patient a therapeutically effective amount of a compound of the invention, either alone or in combination with a therapeutically effective amount of one or more beta-lactamase inhibitor compounds.

  本发明涉及式（I）的双环芳基单内酰胺化合物及其药学上可接受的盐，其中 A1、L、M、W、X、Y、Z、RX 和 Rz 如本文所定义。本发明还涉及包含本发明的双环芳基单内酰胺化合物或其药学上可接受的盐以及药学上可接受的载体的组合物。本发明进一步涉及治疗细菌感染的方法，包括向患者施用治疗有效量的本发明化合物，可单独施用或与治疗有效量的一种或多种β-内酰胺酶抑制剂化合物联合施用。